Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 481 | 352 | 291 | 57 | 0 |
| Cost of Goods | 140 | N/A | N/A | N/A | N/A |
| Gross Profit | 341 | 352 | 291 | 57 | N/A |
| Operating Expenses | 8,238 | 10,028 | 31,022 | 6,957 | 5,175 |
| Operating Income | -7,757 | -9,676 | -30,731 | -6,900 | -5,175 |
| Interest Expense | 607 | 539 | 911 | 3,514 | 7,436 |
| Other Income | 827 | -7,125 | 211 | -11,503 | -813 |
| Pre-tax Income | -7,537 | -17,340 | -31,431 | -21,917 | -13,424 |
| Income Tax | N/A | N/A | N/A | -61 | -173 |
| Net Income Continuous | -7,537 | -17,340 | -31,431 | -21,856 | -13,251 |
| Net Income Discontinuous | N/A | N/A | N/A | 112 | 377 |
| Net Income | $-7,537 | $-17,340 | $-31,431 | $-21,744 | $-12,874 |
| EPS Basic Total Ops | -750.00 | -2,037.50 | -5,200.00 | -12,900.00 | -4,562.50 |
| EPS Basic Continuous Ops | -602.65 | -1,833.91 | -4,702.99 | -12,937.50 | -4,700.00 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 37.50 | 137.50 |
| EPS Diluted Total Ops | -750.00 | -2,037.50 | -5,200.00 | -12,900.00 | -4,562.50 |
| EPS Diluted Continuous Ops | -602.65 | -1,833.91 | -4,702.99 | -12,937.50 | -4,700.00 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 37.50 | 137.50 |
| EBITDA(a) | $-7,519 | $-9,417 | $-30,151 | $-4,305 | $1,883 |